Friday, 1 May 2026European Markets

#GAMMAGARD S/D

1 article

Takeda to Discontinue GAMMAGARD S/D by End of 2027, Raising Concerns Over European Immunoglobulin Supply

Healthcare Regulation

Takeda to Discontinue GAMMAGARD S/D by End of 2027, Raising Concerns Over European Immunoglobulin Supply

ViaNews Editorial Team (Europe)•Feb 18, 2026